Agilon Health, INC Form 4 insider transactions

Denise Zamore, Chief Legal Officer of agilon health, inc., reported a transaction in 37 shares of common stock on August 1, 2026.

Agilon Health's Chief Financial Officer, Jeffrey A. Schwaneke, acquired 2,311 shares of common stock on July 1, 2026, through a net settlement of restricted stock units to cover tax obligations.

Chief Legal Officer Denise Zamore reported a routine withholding of 485 shares to cover tax obligations related to restricted stock units.

Director John William Wulf was granted 2,133 restricted stock units as part of his compensation, following a recent 1-for-25 reverse stock split.

Director Ronald A. Williams received 2,133 restricted stock units following the company's recent 1-for-25 reverse stock split.

Director Karen McLoughlin was granted 2,133 restricted stock units following the company's recent 1-for-25 reverse stock split.

Director Diana McKenzie was granted 2,133 restricted stock units as part of her compensation, following a recent 1-for-25 reverse stock split.

Director Sharad Mansukani received a grant of 2,133 restricted stock units as part of his compensation, following a significant reverse stock split earlier this year.

Director Silvana Battaglia was awarded 2,133 restricted stock units as part of her compensation following a recent 1-for-25 reverse stock split.

Chief Accounting Officer Timothy Gertsch reported a net settlement of restricted stock units for tax obligations.

Agilon Health, Inc. executive Timothy Patrick O'Rourke reported transactions involving restricted stock units and performance stock units.

Chief Legal Officer Denise Zamore reported the withholding of 240 shares of agilon health common stock to satisfy tax obligations.

Agilon Health Chief Technology Officer Girish Venkatachaliah reported the withholding of 426 shares to cover tax obligations related to restricted stock units.

Chief Accounting Officer Timothy Gertsch reported the withholding of 147 shares of common stock to satisfy tax obligations.

Benjamin Shaker, Chief Markets Officer of agilon health, inc., reported the withholding of 675 shares to satisfy tax obligations.

Agilon Health's Chief Financial Officer, Jeffrey A. Schwaneke, acquired shares and was granted restricted stock units, reflecting ongoing equity-based compensation and ownership.

Agilon Health's Chief Markets Officer, Benjamin Shaker, reported transactions involving common stock and restricted stock units.

Agilon Health Chief Accounting Officer Timothy Gertsch reported transactions involving common stock and restricted stock units.

Girish Venkatachaliah, Chief Technology Officer at Agilon Health, Inc., reported transactions involving common stock and restricted stock units.

Agilon Health's Chief Legal Officer, Denise Zamore, reported transactions involving the acquisition of 50,000 restricted stock units and the withholding of 1,024 shares for tax obligations.

Agilon Health's Chief Markets Officer, Benjamin Shaker, reported a planned acquisition of 500,000 common shares at a weighted average price of $0.6021, effective March 2, 2026, under a Rule 10b5-1 plan.

Agilon Health Director John William Wulf acquired 81,000 shares of common stock in a pre-planned transaction, increasing his beneficial ownership.

Agilon Health's Chief Financial Officer, Jeffrey A. Schwaneke, was granted 600,000 restricted stock units, vesting over three years starting January 10, 2026.

Agilon Health's Chief Accounting Officer, Timothy Gertsch, had 406 shares withheld for tax obligations related to restricted stock units.

Agilon Health's Chief Legal Officer, Denise Zamore, reported the withholding of 915 common shares for tax obligations related to restricted stock unit settlement.

Agilon Health, Inc.'s Chief Financial Officer, Jeffrey A. Schwaneke, reported a disposition of 46,099 shares of common stock for tax withholding purposes related to restricted stock units.

Agilon Health's Chief Financial Officer, Jeffrey A. Schwaneke, reported the withholding of 9,331 shares of common stock by the issuer to cover tax obligations related to restricted stock units.

Diana McKenzie, a Director at agilon health, inc., was granted 78,724 restricted stock units (RSUs) on May 28, 2025, which are set to vest in full on May 28, 2026.

Agilon Health, Inc. Director John William Wulf was granted 78,724 restricted stock units on May 28, 2025, increasing his total beneficial ownership to 284,857 shares.

Agilon Health, Inc. Director Ronald A. Williams has acquired 78,724 shares of common stock in the form of restricted stock units, increasing his total beneficial ownership to over 3.6 million shares.